Autologous tumor immunoglobulin idiotype (Id)

The autologous tumor immunoglobulin idiotype is a unique antigenic determinant found within the variable regions (heavy and light chains) of the B-cell receptor (BCR) expressed by a specific patient's malignant B-cell clone. Since B-cell lymphomas and leukemias are monoclonal in origin, the idiotype serves as a truly tumor-specific antigen (TSA) that is not present on healthy B cells or other tissues. In therapeutic applications, the idiotype is typically harvested from the patient's own tumor cells, purified, and often conjugated to a carrier protein like Keyhole Limpet Hemocyanin (KLH) to enhance its visibility to the immune system. When administered as a vaccine, it is intended to stimulate the patient's immune system to recognize and destroy the cancerous B-cell population. While this personalized approach offers high specificity and minimal off-target toxicity, its clinical utility has been limited by the logistical challenges of custom manufacturing and the need for robust immune-stimulating adjuvants.

Other names

B-cell receptor idiotypeTumor-specific idiotypePatient-specific idiotypeImmunoglobulin idiotypeIg-Id

Active immunotherapy designed to induce a patient-specific humoral and cellular immune response against the unique variable region of the monoclonal immunoglobulin expressed on the surface of malignant B cells.